Loading...

DRIO DARIOHEALTH CORP Capital Structure Changes 8-K Filing

DRHL

DR

DARIOHEALTH CORP

(DRIO)

2024 8-K

Stock Offering Agreement

Annual Meeting Results

Credit Agreement Update

Stock Offering Update

Stock Conversion Update

Regained Compliance

Reverse Stock Split

Rights Offerings

Amendments to Preferred Stock

Debt-Equity Swaps

Equity Offerings

Management Changes

Nasdaq Compliance

Private Placement

Annual Meeting Results

Nasdaq Compliance Notice

Preferred Stock Changes

Equity Incentive Plan Amend...

Appointment and Departure

Bylaws Amendment

Salary Increase and Bonus A...

Offering Closed

Investor Presentation

Merger Agreement and Privat...

Annual Meeting Voting Results

Investor Presentation

Earnings Guidance

Warrant Amendment Agreement

Securities Purchase Agreeme...

Regulation FD Disclosure

Appointment of Director

Financial Results

Termination of Employment

Agreement with Plaintiff in...

External Links:

DarioHealth Corp. amended its Series B-3 Preferred Stock terms, extending the mandatory conversion period from 15 to 18 months and increasing dividends to 10% for the fifth quarter and 25% for the sixth quarter.

AI Assistant

DARIOHEALTH CORP

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.